Vulvar Squamous Cell Carcinoma

13 clinical trials · Condition

Record	Firm	Date
Cisplatin+Pembrolizumab+RT in Vulvar Cancer (NCT04430699)	Massachusetts General Hospital	2020-07-29
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625)	National Cancer Institute (NCI)	2017-09-27
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer (NCT02140021)	M.D. Anderson Cancer Center	2014-10-27
Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva (NCT01595061)	Gynecologic Oncology Group	2012-07-02
Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection (NCT01500512)	Gynecologic Oncology Group	2012-01-03
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva (NCT00068406)	Gynecologic Oncology Group	2005-01-01
Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442)	Gynecologic Oncology Group	1992-06-01

Every clearance here is in the API, with alerts when new ones post.